Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Asset Resilience Ratio

Latest as of December 2022: 2.54%

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has an Asset Resilience Ratio of 2.54% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Hunan Dajiaweikang Pharmaceutical Indust for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥100.00 Million

≈ $14.63 Million USD Cash + Short-term Investments

Total Assets

CN¥3.93 Billion

≈ $575.29 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2022)

This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Asset Resilience Ratio has changed over time. See Hunan Dajiaweikang Pharmaceutical Indust book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hunan Dajiaweikang Pharmaceutical Indust (301126) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥100.00 Million	2.54%
Total Liquid Assets	CN¥100.00 Million	2.54%

Asset Resilience Insights

Limited Liquidity: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd maintains only 2.54% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ji Yao Holding Group Co Ltd SHE:300108	Pharmaceutical Retailers	-0.02%
Raia Drogasil S.A SA:RADL3	Pharmaceutical Retailers	0.08%
Empreendimentos Pague Menos S.A SA:PGMN3	Pharmaceutical Retailers	0.88%
d1000 Varejo Farma Participações S.A SA:DMVF3	Pharmaceutical Retailers	0.59%
High Tide Inc V:HITI	Pharmaceutical Retailers	0.03%
Yifeng Pharmacy SHG:603939	Pharmaceutical Retailers	19.16%
Laobaixing Pharmacy SHG:603883	Pharmaceutical Retailers	0.01%
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A SHE:301408	Pharmaceutical Retailers	0.94%

Annual Asset Resilience Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2022–2022)

The table below shows the annual Asset Resilience Ratio data for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	2.54%	CN¥100.00 Million ≈ $14.63 Million	CN¥3.93 Billion ≈ $575.29 Million	--

pp = percentage points

About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

SHE:301126 China Pharmaceutical Retailers

Market Cap

$357.38 Million

CN¥2.44 Billion CNY

Market Cap Rank

#14231 Global

#4477 in China

Share Price

CN¥11.89

Change (1 day)

+1.28%

52-Week Range

CN¥10.22 - CN¥14.35

All Time High

CN¥36.14